Terms: = Brain cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132 AND Prognosis
6 results:
1. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies.
Jin J; Duan J; Du L; Xing W; Peng X; Zhao Q
Front Immunol; 2022; 13():1027756. PubMed ID: 36505409
[TBL] [Abstract] [Full Text] [Related]
2. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract] [Full Text] [Related]
3. Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing keap1/NRF2 and CBS-regulated ferroptosis.
Zheng XJ; Chen WL; Yi J; Li W; Liu JY; Fu WQ; Ren LW; Li S; Ge BB; Yang YH; Zhang YZ; Yang H; Du GH; Wang Y; Wang JH
Acta Pharmacol Sin; 2022 Nov; 43(11):2977-2992. PubMed ID: 35581292
[TBL] [Abstract] [Full Text] [Related]
4. Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects.
Shahcheraghi SH; Salemi F; Peirovi N; Ayatollahi J; Alam W; Khan H; Saso L
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011412
[TBL] [Abstract] [Full Text] [Related]
5. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
6. Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.
Kanamori M; Higa T; Sonoda Y; Murakami S; Dodo M; Kitamura H; Taguchi K; Shibata T; Watanabe M; Suzuki H; Shibahara I; Saito R; Yamashita Y; Kumabe T; Yamamoto M; Motohashi H; Tominaga T
Neuro Oncol; 2015 Apr; 17(4):555-65. PubMed ID: 25304134
[TBL] [Abstract] [Full Text] [Related]
